🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase IIa, open-label, repeat-dose trial to investigate the pharmacokinet...
Status
Completed
Location
Research Site
Start Date
2017-11-23
Trial ID
NCT03276078
Treatments Being Tested
This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Status
Completed
Location
Research Site
Start Date
2016-07-05
Trial ID
NCT02796677
The purpose of this Phase III study is to evaluate the long-term safety and...
Status
Completed
Location
Forest Investigative Site 1827
Start Date
2012-04
Trial ID
NCT01572792
The purpose of the study is to compare the efficacy, safety and tolerabilit...
Status
Completed
Location
Almirall Investigational Site
Start Date
2013-09
Trial ID
NCT01908140
Treatments Being Tested
The purpose of this Phase III study is to assess the maintenance bronchodil...
Status
Completed
Location
Forest Investigative Site 1827
Start Date
2011-09
Trial ID
NCT01437397
The purpose of this study is to evaluate the efficacy of this multicenter, ...
Status
Completed
Location
Forest Investigative Site 0909
Start Date
2009-12
Trial ID
NCT01049360
This is a multiple dose, randomised, parallel, double blind, double dummy, ...
Status
Completed
Location
Research Site
Start Date
2017-02-02
Trial ID
NCT03022097
This will be a phase IV, open label, multicenter, randomized pragmatic stud...
Status
Terminated
Location
Istituti Clinici Scientifici Maugeri, Pneumologia Riabilitativa
Start Date
2018-11-11
Trial ID
NCT03662711
Treatments Being Tested
The purpose of this study is to evaluate discontinuation rates of roflumila...
Status
Completed
Location
Multiple Locations
Start Date
2014-05-01
Trial ID
NCT02165826
Treatments Being Tested
The purpose of this study is to assess the long-term safety and tolerabilit...
Status
Completed
Location
Forest Investigative Site 1162
Start Date
2011-09-19
Trial ID
NCT01437540
Treatments Being Tested